Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis [Phase 3]
Phase 3 trial update evaluating sofobuvir/velpatasvir with or without ribavirin for 12 weeks in adults with chronic HCV and decompensated ci…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Screening for Hepatitis C During Pregnancy at a Toronto Inner City Prenatal Clinic
Clinical trial update indicating the study evaluating Hepatitis C screening during pregnancy at an inner-city Toronto prenatal clinic has co…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus [Phase 3]
A Phase 3 trial evaluating sofosbuvir and daclatasvir for hepatitis C in 200 patients co-infected with HIV has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients [Phase 3]
Phase 3 trial evaluating the efficacy of grazoprevir/elbasvir in early chronic hepatitis C among HIV/HCV co-infected patients.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection [Phase 3]
Phase 3 clinical trial completed evaluating ABT-493/ABT-530 in Japanese adults with genotype 2 chronic hepatitis C virus infection; results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients [Phase 4]
Phase 4 trial evaluating Sofosbuvir and Daclatasvir in 1000 Hepatitis C patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Study of Combination Treatment With IMO-2125 and Ribavirin in Naïve Hepatitis C-infected, Genotype 1 Patients [Phase 1]
Phase 1 study evaluating the safety and preliminary efficacy of combining IMO-2125 with ribavirin in treatment-naïve genotype 1 hepatitis C …
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 (Immunomodulatory Oligonucleotide) in Hepatitis C-infected Patients [Phase 1]
Phase 1, placebo-controlled, dose-escalation study assessing the safety of IMO-2125 in hepatitis C patients; results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) [NA]
A completed clinical trial compares education alone to education plus intervention for diagnosing HIV and hepatitis C virus coinfection.
-
CLINICAL_TRIALS trial_result · 2019-02-11Clinical Trial Update: Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort
A real-world Spanish cohort study reports on the effectiveness, safety, and clinical outcomes of elbasvir/grazoprevir for hepatitis C.
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Adult-to-Adult Living Donor Transplant Cohort Study
The Clinical Trials entry indicates that the Adult-to-Adult Living Donor Transplant Cohort Study has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study) [Phase 3]
Phase 3 study evaluating the efficacy and safety of narlaprevir boosted with ritonavir in treatment-naïve and pegylated interferon/ribavirin…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed-Dose Combination in HCV-Infected Adults Who Are Undergoing Liver Transplantation [Phase 2]
Phase 2 study evaluating the fixed-dose combination sofosbuvir/velpatasvir (Epclusa) in adults with hepatitis C undergoing liver transplanta…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Tool to Improve Treatment Adherence and Outcomes at Grady Liver Clinic [NA]
Completed clinical trial evaluating a tool to improve treatment adherence and outcomes for hepatitis C at Grady Liver Clinic.
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infection
This is a completed use-results surveillance study of Harvoni (ledipasvir/sofosbuvir) in Japanese patients with chronic genotype 1 Hepatitis…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral Agents
The completed trial update reports cognitive changes observed in hepatitis C patients after successful eradication of the virus with direct-…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Hepatitis C Infection in World Trade Center Responders
Completed clinical trial update evaluating Hepatitis C infection in World Trade Center responders.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: C Tracker, Hepatitis C, Care & Collaboration - Patient Reported Outcomes Survey Study
The C Tracker Hepatitis C patient-reported outcomes survey study led by Boston Children's Hospital has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Racial Difference in HCV/Host Interactions
An NIAID-funded clinical trial examining racial differences in host interactions with hepatitis C virus has completed. The update discusses …
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania
A completed clinical trial in Romania evaluated the effectiveness of the hepatitis C regimen Paritaprevir/ritonavir/ombitasvir plus dasabuvi…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection [Phase 2]
Phase 2 trial update on combinations of AL-335, Odalasvir and Simeprevir for chronic hepatitis C; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: Daclatasvir, Asunaprevir Plus Ribavirin for HCV Genotype 1b Without NS5A RAV [Phase 3]
Phase 3 trial update on daclatasvir, asunaprevir plus ribavirin for hepatitis C genotype 1b without NS5A resistance-associated variants has …
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: 8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis [Phase 3]
Phase 3 trial comparing 8 weeks vs 12 weeks of elbasvir/grazoprevir in treatment-naïve chronic hepatitis C with mild fibrosis completed.
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV [Phase 3]
Phase 3 trial evaluating sofobuvir/velpatasvir fixed-dose combination over 12 weeks for chronic hepatitis C shows efficacy and safety result…
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study
An observational study assessing the effectiveness of paritaprevir/ritonavir-ombitasvir ± dasabuvir ± ribavirin in patients with chronic hep…